Bausch Health Companies Inc.·4

Feb 27, 5:12 PM ET

APPIO THOMAS 4

Research Summary

AI-generated summary

Updated

Bausch Health (BHC) CEO Thomas Appio Receives RSU Award; Shares Withheld

What Happened

  • Thomas Appio, CEO of Bausch Health Companies Inc. (BHC), received an award of 815,425 restricted share units (RSUs) on 2026-02-25 (reported as an acquisition/award). On 2026-02-26 the filing shows 116,502 shares were disposed to satisfy tax withholding obligations at $6.04 per share, totaling about $703,672.
  • The RSUs were granted at $0 acquisition price (standard for RSU awards). The withholding transaction (code F) is a tax-related disposition, not an open-market sale.

Key Details

  • Transaction dates: Grant 2026-02-25 (A); tax withholding disposal 2026-02-26 (F).
  • Withholding price and value: 116,502 shares × $6.04 = $703,672 (disposed/withheld).
  • Vesting schedule (footnote): The awarded RSUs vest one‑third on each of the first three anniversaries after the grant date and will be settled in common shares (footnote F1).
  • Withheld shares explanation (footnote F2): 116,502 common shares were withheld to satisfy tax withholding on RSU vesting.
  • Shares owned after the transaction: Not stated in the provided filing excerpt.
  • Filing timeliness: Report filed 2026-02-27 for transactions on 2026-02-25/26 — appears timely (Form 4 is typically due within two business days).

Context

  • RSU awards are compensation-based grants that deliver shares if/when they vest; the tax-withholding disposal is routine and does not necessarily indicate a buy/sell signal by the insider.
  • This was not an open-market sale or purchase; the disposed shares were withheld for taxes rather than sold in the market.